JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1366 Rocuronium Bromide

Summary: TGF-βR I kinase inhibitor

≥30.48 mg/mL
A1755 Tenofovir Disoproxil Fumarate

Target: Reverse Transcriptases

Summary: Antiretroviral agent( HIV-1 RT inhibitor)

≥31.78 mg/mL
A2559 Altretamine

Summary: Antineoplastic agent

insoluble in H2O; ≥36.3 mg/mL
A1185 BMS-754807

Target: Insulin and Insulin-like Receptors

Summary: IGF-1R/InsR inhibitor,potent and selective

≥23.05 mg/mL
A1805 Imatinib Mesylate (STI571)

2 Citation

Target: PDGFR|c-Kit|Bcr-Abl

Summary: Abl/c-kit/PDGFR inhibitor

≥29.5 mg/mL
A1723 Roscovitine (Seliciclib,CYC202)

2 Citation

Summary: CDK inhibitor,potent and selective

insoluble in H2O; ≥17.72 mg/mL
A2213 17-DMAG (Alvespimycin) HCl

1 Citation

Target: HSP90

Summary: Hsp90 inhibitor

≥26.2 mg/mL
A1266 WYE-354

Summary: MTOR inhibitor,potent,ATP-competitive and cell-permeable

≥49.6 mg/mL
A1748 Ramelteon

1 Citation

Target: Melatonin Receptors

Summary: Agonist of melatonin receptor(M1-M2),highly selective

insoluble in H2O; ≥12.95 mg/mL
A2986 ADL5859 HCl

Summary: δ-opioid receptor agonist,selective

≥21.45 mg/mL